Prevalence and Clonal Characterization of Streptococcus pyogenes Clinical Isolates with Reduced Fluoroquinolone Susceptibility in Spain
- 1 January 2010
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (1), 93-97
- https://doi.org/10.1128/aac.00780-09
Abstract
The aim of this study was to determine the prevalence and characteristics of non-fluoroquinolone (FQ)-susceptible Streptococcus pyogenes isolates and to study their mechanisms of resistance. We performed a prospective prevalence study with 468 isolates collected from 2005 to 2007 and a retrospective study that was based on the examination of existing data collected from 1999 to 2008. The retrospective study included data for isolates with high-level resistance (HR) to ciprofloxacin (MIC ≥ 32 μg/ml) (HR isolates) and isolates with the same emm types as those reported in the literature with low-level resistance (LR) to ciprofloxacin (MICs, 2 to 8 μg/ml) (LR isolates, n = 205). Genetic characterization of the isolates was performed by means of emm typing and multilocus sequence typing. The prevalence of LR ranged from 1.9% in 2005 to 30.8% in 2007. This increase was mainly due to the circulation of an emm 6 subtype ( emm 6.4) that represented 77.1% of the LR isolates in 2007. Notably, another emm 6 subtype, also detected in 2007 ( emm 6.37), showed coresistance to 14- and 15-membered macrolides mediated by the mefA gene. Only three HR isolates were detected (isolates emm 68.1/ST247/T3,13,B3264, emm 77/ST399/T28, and emm 28/ST52/T28), and all were identified in the retrospective study. Overall, the 673 isolates represented 25 emm types. All LR isolates were clustered into two emm types: emm 6 (six emm 6 subtypes) and emm 75. All the 156 emm 6 isolates had LR, harbored the Ser79/Ala mutation in the parC gene product, and had the same sequence type (ST), ST382. Most (21/33) of the emm 75 isolates had LR, showed the Ser79/Phe plus Asp91/Asn double mutation in the parC gene product, and were ST150. The Asp91/Asn mutation by itself did not confer resistance to FQs.Keywords
This publication has 26 references indexed in Scilit:
- Changes in Fluoroquinolone-ResistantStreptococcus pneumoniaafter 7-Valent Conjugate Vaccination, SpainEmerging Infectious Diseases, 2009
- An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenesDiagnostic Microbiology and Infectious Disease, 2008
- Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, SpainInternational Journal of Antimicrobial Agents, 2007
- Phenotypic and Genotypic Characterization of Streptococcus pyogenes Isolates Displaying the MLS B Phenotype of Macrolide Resistance in Spain, 1999 to 2005Antimicrobial Agents and Chemotherapy, 2007
- Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, SpainClinical Microbiology & Infection, 2005
- Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenesJournal of Antimicrobial Chemotherapy, 2005
- Antimicrobial Susceptibility Survey of Streptococcus pyogenes Isolated in Japan from Patients with Severe Invasive Group A Streptococcal InfectionsAntimicrobial Agents and Chemotherapy, 2005
- Streptococcus pyogenes Pharyngeal Isolates with Reduced Susceptibility to Ciprofloxacin in Spain: Mechanisms of Resistance and Clonal DiversityAntimicrobial Agents and Chemotherapy, 2005
- High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in GermanyClinical Microbiology & Infection, 2004
- Dissemination of emm 28 Erythromycin-, Clindamycin- and Bacitracin-Resistant Streptococcus pyogenes in SpainEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004